Vanguard Group
RMTI icon

Vanguard Group’s Rockwell Medical RMTI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.02M Hold
1,205,410
﹤0.01% 3738
2025
Q1
$1.36M Buy
1,205,410
+1,500
+0.1% +$1.7K ﹤0.01% 3614
2024
Q4
$2.46M Hold
1,203,910
﹤0.01% 3497
2024
Q3
$4.78M Buy
1,203,910
+85,633
+8% +$340K ﹤0.01% 3287
2024
Q2
$1.97M Hold
1,118,277
﹤0.01% 3554
2024
Q1
$1.86M Buy
1,118,277
+43,302
+4% +$71.9K ﹤0.01% 3617
2023
Q4
$2.03M Buy
1,074,975
+698,160
+185% +$1.32M ﹤0.01% 3596
2023
Q3
$784K Buy
376,815
+132,896
+54% +$276K ﹤0.01% 3918
2023
Q2
$1.33M Buy
243,919
+22,100
+10% +$121K ﹤0.01% 3808
2023
Q1
$401K Hold
221,819
﹤0.01% 4181
2022
Q4
$225K Buy
221,819
+161
+0.1% +$163 ﹤0.01% 4290
2022
Q3
$293K Sell
221,658
-46,829
-17% -$61.9K ﹤0.01% 4350
2022
Q2
$346K Sell
268,487
-2,684,901
-91% -$3.46M ﹤0.01% 4371
2022
Q1
$1.39M Sell
2,953,388
-538,154
-15% -$254K ﹤0.01% 4108
2021
Q4
$1.43M Sell
3,491,542
-60,097
-2% -$24.6K ﹤0.01% 4157
2021
Q3
$2.12M Sell
3,551,639
-66,389
-2% -$39.6K ﹤0.01% 4041
2021
Q2
$3.29M Sell
3,618,028
-5,487
-0.2% -$4.99K ﹤0.01% 3800
2021
Q1
$4.2M Buy
3,623,515
+835,055
+30% +$969K ﹤0.01% 3619
2020
Q4
$2.82M Buy
2,788,460
+157,096
+6% +$159K ﹤0.01% 3569
2020
Q3
$2.81M Sell
2,631,364
-524,661
-17% -$561K ﹤0.01% 3386
2020
Q2
$6.15M Buy
3,156,025
+109,283
+4% +$213K ﹤0.01% 3006
2020
Q1
$6.25M Buy
3,046,742
+280,068
+10% +$574K ﹤0.01% 2854
2019
Q4
$6.75M Sell
2,766,674
-142,464
-5% -$348K ﹤0.01% 3053
2019
Q3
$8.03M Buy
2,909,138
+55,880
+2% +$154K ﹤0.01% 2927
2019
Q2
$8.59M Buy
2,853,258
+605,032
+27% +$1.82M ﹤0.01% 2949
2019
Q1
$12.8M Buy
2,248,226
+619,060
+38% +$3.52M ﹤0.01% 2695
2018
Q4
$3.68M Sell
1,629,166
-708,328
-30% -$1.6M ﹤0.01% 3192
2018
Q3
$9.86M Sell
2,337,494
-2,198
-0.1% -$9.28K ﹤0.01% 2927
2018
Q2
$11.5M Buy
2,339,692
+68,840
+3% +$339K ﹤0.01% 2832
2018
Q1
$11.8M Buy
2,270,852
+18,258
+0.8% +$95.1K ﹤0.01% 2748
2017
Q4
$13.1M Buy
2,252,594
+83,059
+4% +$483K ﹤0.01% 2698
2017
Q3
$18.6M Buy
2,169,535
+88,692
+4% +$759K ﹤0.01% 2520
2017
Q2
$16.5M Buy
2,080,843
+90,786
+5% +$720K ﹤0.01% 2541
2017
Q1
$12.5M Buy
1,990,057
+93,589
+5% +$586K ﹤0.01% 2664
2016
Q4
$12.4M Buy
1,896,468
+30,441
+2% +$199K ﹤0.01% 2646
2016
Q3
$12.5M Buy
1,866,027
+33,912
+2% +$227K ﹤0.01% 2581
2016
Q2
$13.9M Buy
1,832,115
+83,440
+5% +$632K ﹤0.01% 2492
2016
Q1
$13.1M Buy
1,748,675
+85,155
+5% +$640K ﹤0.01% 2471
2015
Q4
$17M Buy
1,663,520
+50,319
+3% +$515K ﹤0.01% 2369
2015
Q3
$12.4M Buy
1,613,201
+87,929
+6% +$678K ﹤0.01% 2490
2015
Q2
$24.6M Buy
1,525,272
+46,378
+3% +$748K ﹤0.01% 2262
2015
Q1
$16.2M Buy
1,478,894
+148,288
+11% +$1.62M ﹤0.01% 2415
2014
Q4
$13.7M Buy
1,330,606
+294,958
+28% +$3.03M ﹤0.01% 2408
2014
Q3
$9.47M Buy
1,035,648
+50,526
+5% +$462K ﹤0.01% 2522
2014
Q2
$11.8M Buy
985,122
+12,507
+1% +$150K ﹤0.01% 2434
2014
Q1
$12.3M Buy
972,615
+127,851
+15% +$1.62M ﹤0.01% 2390
2013
Q4
$8.82M Buy
844,764
+83,479
+11% +$872K ﹤0.01% 2521
2013
Q3
$8.69M Buy
761,285
+36,840
+5% +$420K ﹤0.01% 2464
2013
Q2
$2.62M Buy
+724,445
New +$2.62M ﹤0.01% 2973